MoonLake Immunotherapeutics (MLTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MoonLake Immunotherapeuti...

    NASDAQ: MLTX · Real-Time Price · USD
    61.99
    5.61 (9.95%)
    At close: Sep 26, 2025, 3:59 PM
    61.96
    -0.05%
    After-hours: Sep 26, 2025, 07:55 PM EDT

    MoonLake Immunotherapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 1.38M 13.16K 12.36K 4.97K
    Gross Profit
    		 -1.38M -13.16K -12.36K -4.97K
    Operating Income
    		 -143.09M -54.12M -65.06M -53.58M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -120.96M -43.98M -64.47M -53.64M
    Net Income
    		 -118.94M -36.01M -64.51M -53.64M
    Selling & General & Admin
    		 30.32M 22.32M 23.01M 18.05M
    Research & Development
    		 111.39M 31.79M 42.05M 35.52M
    Other Expenses
    		 1.38M n/a 591.73K n/a
    Operating Expenses
    		 143.09M 54.12M 65.06M 53.57M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 -30.29B n/a n/a 18.03M
    Cost & Expenses
    		 143.09M 54.12M 65.06M 53.58M
    Income Tax Expense
    		 282.2K 94.39K 36.37K 4.75K
    Shares Outstanding (Basic)
    		 62.87M 49.12M 29.36M 7.84M
    Shares Outstanding (Diluted)
    		 62.87M 49.12M 29.36M 7.84M
    EPS (Basic)
    		 -1.89 -0.73 -2.2 -6.84
    EPS (Diluted)
    		 -1.89 -0.73 -2.2 -6.84
    EBITDA
    		 -119.58M -54.11M -65.05M -53.63M
    EBIT
    		 -120.96M -54.12M -65.06M -53.64M
    Depreciation & Amortization
    		 1.39M 13.16K 12.36K 4.97K

    Add to Watchlist